Mr. James Durward reports

NDATALYZE CORP. ("NDAT" OR THE "CORPORATION") (CSE:NDAT) (OTC:NDATF) PROVIDES AN OPERATIONAL UPDATE FOR ITS YMI MACHINE LEARNING-BASED MENTAL HEALTH ASSESSMENT PROGRAM AND ANNOUNCES INITIATION OF ITS B2B CLINICAL DECISION SUPPORT SYSTEM ("CDSS")

Ndatalyze Corp. has provided an operational update for its YMI machine learning-based mental health assessment program and announces initiation of its clinical decision support system (CDSS) program. The corporation reports that its YMI predictive mental health assessment program is fully functional and is being marketed direct-to-consumers (B2C) in New York state and California state. Preliminary statistics are expected at the end of May, 2023, which will help provide direction for B2C marketing and advertising channels. A YMI free trial is available to all at the YMI website.

The corporation further announces that it has initiated the search for a qualified third party institution to conduct a clinical trial in preparation for launch of the clinical decision support system (CDSS) aspect of the YMI application. The YMI CDSS is designed for primary physicians, including those in family medicine and general practice, who are not fully trained in mental health diagnosis and treatment, but are often the first point of contact with the mental health system for patients with mental health concerns. According to the AAMC (Association of American Medical Colleges) there are approximately 120,000 of these primary physicians in the United States. As part of the CDSS program, the corporation will explore strategic relationships with electronic medical records (EMR) and electronic health records (EHR) companies that are seeking to add a mental health aspect to their software offerings. EMR and EHR software platforms are used to manage digital patient charts and are widely used by primary physicians.

About YMI

YMI uses a holistic, evidence-based, objective data from whole-life experiences to predict why you are who you are, and applies this knowledge toward a fuller understanding of how to improve your mental well-being. After registering at the YMI Health website, users gain access to a private, in-depth survey that applies machine learning using a person's genetic expressions, childhood environment, habits, phobias, lived experiences and lifestyle. Upon completion of the questionnaire, YMI generates a personalized graphic report predicting a person's predisposition for seven mental conditions, including anxiety, depression, posttraumatic stress disorder, obsessive compulsive disorder, alcoholism and personality disorders, both current and forward in time. The downloadable report may be used for reference as the user considers changes to their lifestyle that may help improve their mental well-being and mental health journey. The service also helps connect users with therapists who are prepared to help with next steps, providing further clarity and treatment as required.

About Ndatalyze Corp.

Ndatalyze generates technology-based, health-related solutions. Its machine-learning-processed, on-line consumer mental health application, known as YMI, is based on the corporation's proprietary reference database consisting of more than 1,200 biometric records, complete with associated electroencephalogram (EEG) data. YMI has only recently begun its initial staged launch and, accordingly, the corporation cannot accurately predict if or when this application will become a profit generator.

We seek Safe Harbor.